Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $209000.0.

  • Utah Medical Products' Depreciation & Amortization (CF) rose 295.57% to $209000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $814000.0, marking a year-over-year increase of 1831.4%. This contributed to the annual value of $730000.0 for FY2024, which is 1717.5% up from last year.
  • Per Utah Medical Products' latest filing, its Depreciation & Amortization (CF) stood at $209000.0 for Q3 2025, which was up 295.57% from $205000.0 recorded in Q2 2025.
  • Utah Medical Products' Depreciation & Amortization (CF)'s 5-year high stood at $209000.0 during Q3 2025, with a 5-year trough of $149000.0 in Q1 2022.
  • Moreover, its 5-year median value for Depreciation & Amortization (CF) was $158000.0 (2021), whereas its average is $169210.5.
  • As far as peak fluctuations go, Utah Medical Products' Depreciation & Amortization (CF) plummeted by 858.9% in 2022, and later skyrocketed by 3096.77% in 2024.
  • Over the past 5 years, Utah Medical Products' Depreciation & Amortization (CF) (Quarter) stood at $153000.0 in 2021, then rose by 3.27% to $158000.0 in 2022, then changed by 0.0% to $158000.0 in 2023, then rose by 26.58% to $200000.0 in 2024, then grew by 4.5% to $209000.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $209000.0 for Q3 2025, versus $205000.0 for Q2 2025 and $200000.0 for Q1 2025.